ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
-0,98%
Bitcoin
69.410,50
0,11%
Brent Oil
79,395
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. PainReform Ltd (PRFX)

  7. PainReform Ltd (PRFX) Notícias

PRFX

PainReform (PRFX)

PainReform Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRFX
DataHoraFonteTítuloCódigoCompanhia
31/05/202417:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRFXPainReform Ltd
31/05/202417:15GlobeNewswire Inc.PainReform Announces Receipt of Nasdaq Minimum Bid Price NotificationNASDAQ:PRFXPainReform Ltd
15/05/202417:05GlobeNewswire Inc.PainReform Provides Business Update for the First Quarter of 2024NASDAQ:PRFXPainReform Ltd
08/05/202409:30GlobeNewswire Inc.PainReform CEO Ilan Hadar Discusses Latest Developments Related to PRF-110 and its Potential to Help Tackle the Opioid Epidemic on Proactiveinvestors.comNASDAQ:PRFXPainReform Ltd
18/04/202415:19GlobeNewswire Inc.PainReform Announces Closing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
16/04/202409:00GlobeNewswire Inc.PainReform Announces Pricing of $4 Million Public OfferingNASDAQ:PRFXPainReform Ltd
09/04/202410:00GlobeNewswire Inc.PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsNASDAQ:PRFXPainReform Ltd
02/04/202409:30GlobeNewswire Inc.PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical Trial of PRF-110 in BunionectomyNASDAQ:PRFXPainReform Ltd
01/03/202418:34Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:PRFXPainReform Ltd
01/03/202410:00GlobeNewswire Inc.PainReform Provides Year-End Business UpdateNASDAQ:PRFXPainReform Ltd
29/02/202418:37Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PRFXPainReform Ltd
22/01/202410:30GlobeNewswire Inc.PainReform to Present at the Microcap Conference in Atlantic CityNASDAQ:PRFXPainReform Ltd
22/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PRFXPainReform Ltd
19/01/202418:30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PRFXPainReform Ltd
12/01/202418:15Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PRFXPainReform Ltd
03/01/202410:30GlobeNewswire Inc.PainReform Reports Successful Head-to-Head Comparison of PRF-110 Versus Market Leading Post Surgical Analgesia for Extended Postoperative Pain ReliefNASDAQ:PRFXPainReform Ltd
26/12/202320:00GlobeNewswire Inc.PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross ProceedsNASDAQ:PRFXPainReform Ltd
15/11/202318:05GlobeNewswire Inc.PainReform Provides Business Update for the Third Quarter of 2023NASDAQ:PRFXPainReform Ltd
11/09/202309:30GlobeNewswire Inc.PainReform Announces Plans to Commence Second Part of Phase 3 Clinical Trial to Evaluate PRF-110 in Patients Undergoing Bunionectomy Surgery Following Positive FDA Review of Drug Master FileNASDAQ:PRFXPainReform Ltd
07/09/202311:00GlobeNewswire Inc.PainReform Selected for Poster Presentation at the 13th Congress of the European Pain Federation in Budapest, HungaryNASDAQ:PRFXPainReform Ltd
05/09/202309:30GlobeNewswire Inc.PainReform to Participate in the H.C. Wainwright 25th Annual Global Investment Conference in New York CityNASDAQ:PRFXPainReform Ltd
10/08/202317:05GlobeNewswire Inc.PainReform Provides Business Update for the Second Quarter of 2023NASDAQ:PRFXPainReform Ltd
19/07/202310:00GlobeNewswire Inc.PainReform Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:PRFXPainReform Ltd
18/07/202312:59Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRFXPainReform Ltd
14/07/202315:35GlobeNewswire Inc.PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct Offering and Private PlacementNASDAQ:PRFXPainReform Ltd
12/07/202310:05GlobeNewswire Inc.PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private PlacementNASDAQ:PRFXPainReform Ltd
15/06/202309:30GlobeNewswire Inc.PainReform to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21stNASDAQ:PRFXPainReform Ltd
07/06/202317:30GlobeNewswire Inc.PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryNASDAQ:PRFXPainReform Ltd
18/05/202310:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PRFXPainReform Ltd
18/05/202310:00GlobeNewswire Inc.PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy SurgeryNASDAQ:PRFXPainReform Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRFX

Seu Histórico Recente

BTHB
CYBERKRW
CyberConnect
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados